Drug recall: Glenmark, Aurobindo recall multiple products

The company is also recalling around 31,500 bottles of the product in 550 mg strength.

148
Recall
Picture: Pixabay

Last Updated on October 5, 2021 by The Health Master

Glenmark Pharmaceuticals and Aurobindo Pharma are recalling multiple products in the US market due to various reasons like deviation from standard manufacturing protocols and presence of foreign substance in one of the affected lots.

As per the latest enforcement report issued by the US Food and Drug Administration (USFDA), Glenmark’s US-based unit is recalling various products in the US market.

The company is recalling 28,658 cartons of Fulvestrant injection (250 mg/5 ml), a medicine used to treat breast cancer, due to “lack of assurance of sterility”, the US health regulator noted in the report.

Glenmark Pharmaceuticals Inc, USA is also recalling 9,552 bottles of Naproxen Sodium Tablets (275 mg), a pain relieving medicine, due to “CGMP (Current Good Manufacturing Practice) deviations”.

The company is also recalling around 31,500 bottles of the product in 550 mg strength.

Besides, Glenmark is recalling 6,552 bottles of Chlorzoxazone tablets (in strengths of USP 375 mg and 750 mg) due to CGMP deviations.

Chlorzoxazone tablets are used for muscle relaxation. The USFDA stated that the company is also recalling around 2.34 lakh bottles (multiple strengths) of Zonisamide capsules, an anti-epilepsy drug, due to CGMP deviations.

The drug firm is also recalling close to 11,000 units of Arformoterol Tartrate Inhalation Solution, indicated for the treatment of chronic obstructive pulmonary disease, for “lack of assurance of sterility”.

Glenmark Pharmaceuticals Inc, USA, initiated the Class II recall of all the affected lots on August 27, 2021.

New Jersey-based Aurobindo Pharma USA Inc, a unit of Aurobindo Pharma, is recalling 2,820 bottles of Metoprolol tartrate tablets “due to presence of foreign substance: product complaints received for the presence of metal wire in one tablet”.

Metoprolol tartrate tablets are used to treat high blood pressure. The company initiated the Class II recall on September 9 this year.

As per USFDA, a Class-II recall is initiated in a situation “in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote”.

Auro Pharma recalls batches of Drug used to treat severe disease

Drug recall: Granules India and Jubilant recall these Drugs

Drug recall: Dr Reddy’s & Zydus Pharma Recall these drugs

Drug Recall: Metformin oral solution batch due to nitrosamine impurity

J&J recalls these Sunscreens after carcinogen found in some sprays

Viona Pharma recalls 21,240 bottles of this Diabetes drug

Woman held for selling fake Cancer Drugs

FDA advisers to review C-19 shots for young kids

New drug combination found effective against C-19 infection: Study

Drug recall: Auro Pharma recalls Drug used to treat severe disease

Govt to introduce needle free Vaccine shortly

Latest Notifications regarding Pharmaceuticals

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner